World champion Jepchirchir fails drugs test

Peres Jepchirchir, an Olympic and World Championships marathon gold medallist, has been provisionally suspended by the Athletics Integrity Unit. The action followed a positive out-of-competition sample for EPO, or erythropoietin. This matters because EPO can increase red blood cell levels and is prohibited when used to enhance performance.

Jepchirchir provided the sample in Kenya before the Sydney Marathon on 30 August 2026. She then won the race in two hours, 18 minutes and 31 seconds, finishing more than three minutes ahead of compatriot Irene Chepet Cheptai. The sample result is an allegation of a rule violation, not a final ruling.

The suspension temporarily removes Jepchirchir from competition while the case proceeds. The article does not state the final outcome or whether any result will be changed. Those consequences generally depend on the investigation, applicable rules, and any hearing or appeal.

EPO stands for erythropoietin. It is a natural substance produced within the kidneys, where it stimulates the creation of new red blood cells. Red blood cells carry oxygen through the bloodstream, so changing their amount can affect endurance. Competitive sport prohibits artificially using EPO because it can alter a key physical system that supports performance.

The article explains that injected EPO increases the number of red blood cells in the bloodstream. Those cells carry oxygen to working muscles. In a marathon, this may help an athlete sustain a demanding pace for longer. The substance is detectable in urine or blood for only a short window, according to the article, making testing an important part of anti-doping work.

A positive sample does not by itself describe the final legal outcome. Jepchirchir has been provisionally suspended while her case proceeds. The article does not give details of a hearing, explanation, or final sanction, so those matters remain unresolved in the reported account.

Marathon performance depends heavily on delivering oxygen to muscles over a long period. EPO can increase the creation of red blood cells, which carry oxygen through the bloodstream. With more oxygen potentially reaching working muscles, an athlete may produce energy aerobically for longer and sustain a faster pace. That is why artificial EPO use is prohibited.

The article describes EPO as a substance produced naturally by the kidneys. When injected, it increases the amount of red blood cells in the bloodstream. In a marathon, this mechanism could support the repeated muscle contractions needed across 42.195 kilometres. It does not remove every limit, but it can affect a central endurance factor: oxygen transport.

The reported sample from Jepchirchir tested positive for EPO, and she was provisionally suspended. The article does not establish that her Sydney result was caused by EPO or state a final sanction. Any effect on her race results depends on the completed anti-doping process and applicable rules.

Based on the marathon victories specifically listed, Jepchirchir had won four major marathon titles, counting Sydney. The total comes from Sydney, New York, Boston, and London. This count uses the article’s named victories rather than trying to infer a larger career total from every achievement mentioned.

Her Sydney win came on 30 August 2026, when she ran two hours, 18 minutes and 31 seconds. The article also lists victories at the New York Marathon in 2021, the Boston Marathon in 2022, and the London Marathon in 2024. Together, those four races produce the requested total.

The article adds that Sydney became the seventh world major in 2025, although it does not provide a complete list of Jepchirchir’s major titles. It also mentions her Olympic and World Championships marathon gold medals, but those are championship victories rather than the four major marathon wins counted here.

A provisional suspension is a temporary competition ban imposed before an anti-doping case reaches its final decision. It is intended to keep an athlete from competing while the evidence and possible explanations are considered. It is not, by itself, a final finding that Jepchirchir committed a violation.

For Jepchirchir, the suspension means she cannot compete during the provisional period under the relevant rules. The article links the action to an out-of-competition sample that tested positive for EPO. It does not report a hearing, a final decision, or a specific length for the suspension.

Earlier race results are not automatically erased simply because a provisional suspension is announced. Generally, results may be disqualified or amended if an anti-doping violation is ultimately established, subject to the governing rules and any appeal. The article does not say whether her Sydney victory or other results have been changed.

The Athletics Integrity Unit, or AIU, is the organisation named in the article as handling Jepchirchir’s case. It provisionally suspended her after an out-of-competition sample tested positive for EPO. Its role is to protect athletics integrity by addressing suspected anti-doping rule violations. The article does not provide a full description of the unit’s structure or powers.

The reported case began with a sample Jepchirchir provided in Kenya before the Sydney Marathon. The sample was tested and found to contain EPO. In general anti-doping investigations, an integrity body reviews testing information, checks relevant records and procedures, and gives the athlete an opportunity to respond under the applicable rules. Those details are general context, not steps confirmed in this article.

The current position is provisional, so the case is not presented as finished. The article does not state whether Jepchirchir has challenged the result, attended a hearing, or received a final sanction. The next consequences depend on the investigation and any later decision or appeal.

Oxygen matters because marathon muscles work continuously for a very long time. They use oxygen to help produce the energy needed for repeated movement. If oxygen delivery cannot meet demand, the athlete must slow down as fatigue grows. Efficient oxygen transport therefore supports both pace and the ability to keep running late in the race.

The article explains that red blood cells carry oxygen to muscles. It also says EPO stimulates the creation of new red blood cells and, when injected, increases their amount in the bloodstream. This shows the key mechanism: blood transports oxygen from the lungs to working muscle. More transport capacity can potentially support sustained effort, although performance depends on many factors.

That mechanism helps explain why EPO is prohibited in competitive sport. Jepchirchir’s sample tested positive for the substance before her Sydney win. Her case remains provisional, and the article does not establish how oxygen delivery affected her performance or what final decision will follow.